Lacosamide Injection, Solution
Product Images NDC 70069-471

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70069-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 01)

Chemical structure diagram of lacosamide, the active ingredient shown in the product data. The diagram depicts the molecular arrangement of atoms and bonds characteristic of lacosamide.*

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 02)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose.' It compares seizure reduction percentages between placebo and lacosamide doses across three studies, showing higher median percent reductions for lacosamide in all studies.*

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 03)

A line graph titled 'Proportion of Patients by Responder Rate for VIMPAT and Placebo Groups in Studies 2, 3, and 4.' The x-axis represents the percent of patients from 0 to 100, and the y-axis shows the responder rate (equal to or greater) ranging from -100% to 100%. Four lines compare placebo and three VIMPAT daily doses (200 mg/day, 400 mg/day, and 600 mg/day) illustrating their responder rates across the patient population.*

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 04)

A survival curve chart comparing placebo and Lacosamide groups over time in days, showing the percentage of patients remaining seizure-free. The plot includes number of patients at risk at various times and statistical data such as p-value, hazard ratio, and confidence interval.*

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 05)

Label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) single-dose vial for intravenous use, manufactured by Somerset Therapeutics, LLC. The label includes dosage storage instructions, a barcode, and manufacturer location (Somerset, NJ). It specifies the product is Rx only and made in India.*

FDA Label Image

Image (7d259027 E0df 41af 8ead 40aebffd8b59 06)

Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection solution in a carton for 10 x 20 mL single-dose vials. Label shows manufacturer Somerset Therapeutics, LLC with address in Somerset, NJ, and notes product is made in India. Includes storage instructions and inactive ingredients list.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.